Medication info
Teriglmets Tab 20/1000 mg

Teriglmets Tab 20/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletTeneligliptin Ditosylate Dihydrate›37.84mg / 1 tablet
Manufacturer / importer
Sinpoong Pharmaceutical Co., Ltd.
Appearance
Pink oval extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202740 · Approved 2022.07.01 · Insurance code 648508040

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Sinpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This drug is used in combination with teneligliptin and metformin to assist in blood sugar control for patients with Type 2 diabetes, and is more effective when taken with diet and exercise therapies. It is used to stabilize blood sugar levels and improve symptoms of diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal. The dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take one 20/1000 mg extended-release tablet once daily. Patients taking the 10/750 mg or 10/500 mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment may be started at the doses of teneligliptin and metformin they were previously taking. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dosage adjusted as appropriate. When administered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20 mg and extended-release metformin 2000 mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another antihyperglycemic agent. Because such a change may affect glycemic control, any change in treatment for patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This drug helps control blood sugar levels. However, it can rarely lead to a serious condition called lactic acidosis, which is a dangerous state caused by the excessive accumulation of lactic acid in the body. Lactic acidosis can occur more frequently in patients with poor kidney function, heart disease, severe infections, or dehydration. Therefore, patients with moderate or severe renal impairment, acute heart failure, or acute myocardial infarction should not take this drug. Additionally, if iodine contrast media is used for radiological examinations, the drug should be discontinued 48 hours prior to the examination and restarted only after confirming normal kidney function. It is recommended that pregnant women or women of childbearing potential avoid using this medication. Caution is required as the risk of hypoglycemia may increase when taken with insulin or sulfonylurea medications. If sudden dizziness, severe abdominal pain, vomiting, or difficulty breathing occurs during use, prompt consultation with a physician is necessary. Additionally, patients with poor liver function, severe pulmonary disease, or severe malnutrition should use this medication cautiously. Elderly patients may experience decreased kidney function, and regular kidney function tests are recommended, with dosage adjustments made as necessary. Alcohol consumption should be avoided during treatment, and regular blood tests are recommended as vitamin B12 levels may drop. If surgery is performed, the medication should be discontinued 48 hours before the surgery, and recomended to restart only after confirming normal kidney function postoperatively. This drug has not been established for safety and efficacy in children, and should not be used in this population. Lastly, this drug should be kept out of reach of children and should not be transferred to another container.

Side effects

  • Severe metabolic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • intestinal obstruction
  • liver dysfunction
  • interstitial pneumonia
  • dermatitis herpetiformis
  • acute pancreatitis
  • dizziness
Show 125 more
  • abdominal distension
  • abdominal discomfort
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyps
  • colon polyps
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • loss of appetite
  • elevated amylase
  • elevated lipase
  • elevated AST (GOT)
  • elevated ALT (GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • potential hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK (CPK)
  • increased serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • upper respiratory infection
  • headache
  • tremor
  • weakness
  • hunger
  • fatigue
  • facial swelling
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision impairment
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • dizziness
  • cerebral infraction
  • diabetic neuropathy
  • sensory abnormalities
  • hepatic coma
  • sensory disturbances
  • sensory loss
  • tension-type headache
  • peripheral neuropathy
  • facial paralysis
  • sciatica
  • orthostatic dizziness
  • muscle weakness
  • low back pain
  • limb pain
  • lumbar spinal canal stenosis
  • tendinitis
  • cervical pain
  • bone pain
  • osteoarthritis
  • osteoporosis
  • muscle cramps
  • foot deformities
  • hypertrophic arthropathy
  • bursitis
  • spinal osteoarthritis
  • intervertebral disc protrusion
  • intervertebral disc disorders
  • spinal ligament ossification
  • spinal foraminal stenosis
  • postmenopausal osteoporosis
  • rotator cuff syndrome
  • gastroenteritis
  • influenza
  • uterine pyometra
  • subcutaneous abscess
  • gastroenteritis
  • musculoskeletal chest pain
  • falls
  • animal bites
  • radius fracture
  • chronic bronchitis
  • hypertrophy of the nasal turbinates
  • arteriosclerosis
  • hypertension
  • hearing loss
  • endolymphatic hydrops
  • vertigo
  • elevated blood creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • pressure ulcer
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • coronary artery disease
  • unstable angina
  • angina
  • otalgia
  • vertigo
  • iron deficiency anemia
  • food allergy
  • breast cancer
  • foot fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture intrusion. It is important to maintain storage temperature between 1 degree Celsius and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Pink oval extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.